Terms: = Liver cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
38 results:
1. Efficacy of transarterial radioembolization using Y-90 resin microspheres versus atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: A matching-adjusted indirect comparison.
Agirrezabal I; Bouattour M; Pinato DJ; D'Alessio A; Brennan VK; Carion PL; Shergill S; Amoury N; Vilgrain V
Eur J Cancer; 2024 Jan; 196():113427. PubMed ID: 37988840
[TBL] [Abstract] [Full Text] [Related]
2. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S; Chen M; Cheng AL; Kaseb AO; Kudo M; Lee HC; Yopp AC; Zhou J; Wang L; Wen X; Heo J; Tak WY; Nakamura S; Numata K; Uguen T; Hsiehchen D; Cha E; Hack SP; Lian Q; Ma N; Spahn JH; Wang Y; Wu C; Chow PKH;
Lancet; 2023 Nov; 402(10415):1835-1847. PubMed ID: 37871608
[TBL] [Abstract] [Full Text] [Related]
3. Cytochrome P2E1 (CYP2E1) Gene Polymorphism as a Potential Prognostic Biomarker in Colorectal cancer.
Moghadas A; Karbalaie Niya MH; Zamani F; Moazzami M; Farhang F; Ajdarkosh H; Khoonsari M; Faraji A; Panahi M; Emtiazi N; Safarnezhad Tameshkel F; Nikkhah M
Asian Pac J Cancer Prev; 2023 Jul; 24(7):2239-2244. PubMed ID: 37505752
[TBL] [Abstract] [Full Text] [Related]
4. Development and Validation of a Machine-Learning Model to Predict Early Recurrence of Intrahepatic Cholangiocarcinoma.
Alaimo L; Lima HA; Moazzam Z; Endo Y; Yang J; Ruzzenente A; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Pawlik TM
Ann Surg Oncol; 2023 Sep; 30(9):5406-5415. PubMed ID: 37210452
[TBL] [Abstract] [Full Text] [Related]
5. Epidemiological trends and novel prognostic evaluation approaches of patients with stage II-IV colorectal neuroendocrine neoplasms: A population-based study with external validation.
Zhao F; Huang L; Wang Z; Wei F; Xiao T; Liu Q
Front Endocrinol (Lausanne); 2023; 14():1061187. PubMed ID: 36817582
[TBL] [Abstract] [Full Text] [Related]
6. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
7. [A Case of Successful treatment of Recurrent Peritoneal Dissemination of Hepatocellular Carcinoma with Atezolizumab plus Bevacizumab Combination Therapy].
Katsura Y; Takeda Y; Ohmura Y; Sakamoto T; Shinke G; Katsuyama S; Ikeshima R; Kawai K; Hiraki M; Sugimura K; Masuzawa T; Takeno A; Hata T; Murata K
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2027-2029. PubMed ID: 35045482
[TBL] [Abstract] [Full Text] [Related]
8. Adenosquamous cancer of the pancreas: A multicenter retrospective study.
Ramia-Angel JM; Jaén-Torrejimeno I; Serrablo-Requejo A; Rodríguez-Laiz GP; López-Guerra D; Abadía-Forcén T; Alenda C; Serradilla-Martín M; Blanco-Fernández G
Gastroenterol Hepatol; 2022; 45(7):543-551. PubMed ID: 34952130
[TBL] [Abstract] [Full Text] [Related]
9. Donafenib Versus Sorafenib in First-Line treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial.
Qin S; Bi F; Gu S; Bai Y; Chen Z; Wang Z; Ying J; Lu Y; Meng Z; Pan H; Yang P; Zhang H; Chen X; Xu A; Cui C; Zhu B; Wu J; Xin X; Wang J; Shan J; Chen J; Zheng Z; Xu L; Wen X; You Z; Ren Z; Liu X; Qiu M; Wu L; Chen F
J Clin Oncol; 2021 Sep; 39(27):3002-3011. PubMed ID: 34185551
[TBL] [Abstract] [Full Text] [Related]
10. Portal Vein Irradiation Stent Plus Chemoembolization versus External Radiotherapy Plus Chemoembolization in Hepatocellular Carcinoma with Portal Vein Tumour Thrombus: A Retrospective Study.
Tan Z; Lu J; Zhu G; Chen L; Wang Y; Zhang Q; Pan T; Wang J; Guo J; Teng G
Cardiovasc Intervent Radiol; 2021 Sep; 44(9):1414-1422. PubMed ID: 34131776
[TBL] [Abstract] [Full Text] [Related]
11. Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment.
Grechko N; Skarbova V; Tomaszewska-Kiecana M; Ramlau R; Centkowski P; Drew Y; Dziadziuszko R; Zemanova M; Beltman J; Nash E; Habeck J; Liao M; Xiao J
Cancer Chemother Pharmacol; 2021 Aug; 88(2):259-270. PubMed ID: 33909097
[TBL] [Abstract] [Full Text] [Related]
12. LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis.
Li J; Dong W; Jiang Q; Zhang F; Dong H
Cancer Biol Ther; 2021 Apr; 22(4):311-323. PubMed ID: 33879018
[TBL] [Abstract] [Full Text] [Related]
13. Survival in untreated hepatocellular carcinoma: A national cohort study.
Kim YA; Kang D; Moon H; Sinn D; Kang M; Woo SM; Chang YJ; Park B; Kong SY; Guallar E; Shin SY; Gwak G; Back JH; Lee ES; Cho J
PLoS One; 2021; 16(2):e0246143. PubMed ID: 33539397
[TBL] [Abstract] [Full Text] [Related]
14. Surgical outcomes of pulmonary metastasectomy in hepatocellular carcinoma patients according to approach method: thoracoscopic versus open approach.
Lee HP; Yun JK; Jung HS; Moon DH; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
World J Surg Oncol; 2021 Jan; 19(1):33. PubMed ID: 33516218
[TBL] [Abstract] [Full Text] [Related]
15. The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
Méndez Romero A; Schillemans W; van Os R; Koppe F; Haasbeek CJ; Hendriksen EM; Muller K; Ceha HM; Braam PM; Reerink O; Intven MPM; Joye I; Jansen EPM; Westerveld H; Koedijk MS; Heijmen BJM; Buijsen J
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1377-1386. PubMed ID: 33451857
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic Significance of Pretreatment 18F-FDG PET/CT Volumetric Parameters in Patients With Colorectal liver Metastasis: A Systematic Review and Meta-analysis.
Kim YI; Lee HS; Choi JY
Clin Nucl Med; 2021 Mar; 46(3):206-213. PubMed ID: 33443946
[TBL] [Abstract] [Full Text] [Related]
17. Hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with HCC: prognostic features before resection, ablation, or TACE.
Bae JS; Kim JH; Lee DH; Kim JH; Han JK
Eur Radiol; 2021 Jun; 31(6):3627-3637. PubMed ID: 33211146
[TBL] [Abstract] [Full Text] [Related]
18. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
Zhu AX; Nipp RD; Finn RS; Galle PR; Llovet JM; Blanc JF; Okusaka T; Chau I; Cella D; Girvan A; Gable J; Bowman L; Wang C; Hsu Y; Abada PB; Kudo M
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817068
[TBL] [Abstract] [Full Text] [Related]
19. Transarterial Chemoembolization of Hepatocellular Carcinoma: Propensity Score Matching Study Comparing Survival and Complications in Patients with Nonalcoholic Steatohepatitis Versus Other Causes Cirrhosis.
Young S; Sanghvi T; Rubin N; Hall D; Roller L; Charaf Y; Golzarian J
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):65-75. PubMed ID: 31686136
[TBL] [Abstract] [Full Text] [Related]
20. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi's criteria.
Kobayashi Y; Kiya Y; Nishioka Y; Hashimoto M; Shindoh J
HPB (Oxford); 2020 Feb; 22(2):258-264. PubMed ID: 31326264
[TBL] [Abstract] [Full Text] [Related]
[Next]
